<qa>  What is the primary outcome measurement?Postoperative recovery after live donor nephrectomy LDN is largely determined by the consequences of postoperative pain and analgesia consumptions. The investigators goal is to establish the relationship between the use of deep neuromuscular blockade NMB during laparoscopic donor nephrectomy LDN and the early quality of recovery. Therefore, the investigators designed a trial in which patients scheduled for living donor nephrectomy are randomized into a group with deep NMB or moderate NMB. The primary outcome measurement will be the Quality of Recovery-40 questionnaire overall score at 48 hours after extubation. 